Bottom line
FACTX vs PRHSX: the short answer
FACTX (Fidelity Advisor Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.
PRHSX is cheaper at 0.83% vs 1.21% — a difference of $38 a year per $10,000 invested.
Over five years, PRHSX returned +4.2% a year vs +2.6% for FACTX (reporting dates differ).
Updated Nov 19, 2026
FACTX vs PRHSX side by side
| FACTX | PRHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.21% | 0.83% |
| Annual cost per $10k | $121 | $83 |
| 10-yr cost on $10k (prospectus) | $1,765 | $1,025 |
| Max front load | — | — |
| 12b-1 fee | 0.5% | — |
| 1-yr return | +10.0% | +17.7% |
| 5-yr return (annualized) | +2.6% | +4.2% |
| 10-yr return (annualized) | +7.6% | +9.1% |
| Best quarter | +21.3% | +23.5% |
| Worst quarter | −15.0% | −15.8% |
| Net assets (fund) | $3.1B | $11.9B |
| Number of holdings | 154 | 279 |
| Portfolio turnover | 74% | 62% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of FACTX's top 25 holdings also appear in PRHSX's top 25.
| Holding | FACTX | PRHSX |
|---|---|---|
| ELI LILLY and CO | 7.66% | 14.28% |
| Danaher Corp | 6.75% | 1.43% |
| Thermo Fisher Scientific Inc | 6.31% | 2.52% |
| Unitedhealth Group Inc | 4.17% | 5.99% |
| JOHNSON and JOHNSON | 3.78% | 6.63% |
| Abbvie Inc | 3.62% | 5.10% |
| MERCK and CO INC | 2.09% | 4.01% |
| Natera Inc | 1.65% | 1.44% |
| Guardant Health Inc | 1.48% | 1.23% |
| Cvs Health Corp | 1.29% | 0.94% |
| Gilead Sciences Inc | 1.25% | 2.82% |
Source: SEC Form N-PORT
FACTX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between FACTX and PRHSX?
FACTX (Fidelity Advisor Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds. PRHSX is cheaper at 0.83% vs 1.21% — a difference of $38 a year per $10,000 invested.
Which is cheaper, FACTX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both FACTX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.